Harpoon Therapeutics Announces Reverse Stock Split Update
PremiumCompany AnnouncementsHarpoon Therapeutics Announces Reverse Stock Split Update
8M ago
Harpoon Therapeutics downgraded to Market Perform from Outperform at TD Cowen
Premium
The Fly
Harpoon Therapeutics downgraded to Market Perform from Outperform at TD Cowen
8M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
8M ago
Harpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyHarpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
8M ago
M & A News: Merck (NYSE:MRK) to Acquire Harpoon for $680 Million
Premium
Market News
M & A News: Merck (NYSE:MRK) to Acquire Harpoon for $680 Million
8M ago
Merck to acquire Harpoon Therapeutics for $23.00 per share in cash
Premium
The Fly
Merck to acquire Harpoon Therapeutics for $23.00 per share in cash
8M ago
Harpoon Therapeutics Abstract for HPN328 Accepted for Rapid Oral Presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium
PremiumPress ReleasesHarpoon Therapeutics Abstract for HPN328 Accepted for Rapid Oral Presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium
9M ago
Harpoon Therapeutics price target raised by $4.50 at H.C. Wainwright, here’s why
Premium
The Fly
Harpoon Therapeutics price target raised by $4.50 at H.C. Wainwright, here’s why
9M ago
Harpoon Therapeutics presents HPN217 Phase 1 data in RRMM
Premium
The Fly
Harpoon Therapeutics presents HPN217 Phase 1 data in RRMM
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100